期刊文献+

脓毒症患者血脂水平与其预后的关系 被引量:7

The prognostic value of serum lipid level for clinical outcome in severe sepsis patients
下载PDF
导出
摘要 目的探讨脓毒症患者血脂水平与其预后的关系。方法记录分析我院43例脓毒症患者的临床资料。按预后情况将患者分为死亡组和存活组,比较两组患者基线分布情况、血脂水平差异,应用ROC曲线分析血脂水平在预测脓毒症患者预后中的价值,并分析血脂水平与疾病严重程度的关系。结果死亡组HDL-C[(0.95±0.04)mmol/L vs(1.19±0.07)mmol/L]和LDL-C[(1.52±0.26)mmol/L vs(2.49±0.33)mmol/L]水平低于存活组,TC[(3.48±0.64)mmol/L vs(2.62±0.47)mmol/L]水平高于存活组,差异具有统计学意义(P<0.05)。HDL-C预测脓毒症死亡风险AUC为0.994,95%CI(0.878,0.957);LDL-C预测脓毒症死亡风险AUC为0.991,95%CI为(0.856,0.943)。TC、HDL-C和LDL-C与APACHEⅡ评分和24 h内SOFA评分最大值存在明显相关性(P<0.05)。结论脓毒症患者TC、HDL-C、LDL水平与疾病的严重程度呈一定的相关性,TC、HDL-C、LDL-C水平可作为预测脓毒症预后的良好指标。 Objective To investigate the value of serum lipid levels for predicting of clinicaloutcomes in patients with sepsis. Methods The clinical date of 43 patients withsepsiswerecollected. All patients were divided to survivor group and non-survivor group. The serum lipid levels were compared. The receiver operator characteristic curve was produced for predicting the hospital motility. To determine the discriminative power of the serum lipid for survival, constructed ROC curves and calculated areas under the curve with 95%CI. The relationship was evaluated by correlation analysis between serum lipid levels and severity of disease. Results The HDL-C[(0.95±0.04)mmol/L vs (1.19±0.07)mmol/L] and LDL-C[(1.52±0.26)mmol/L vs (2.49±0.33)mmol/L] levels in non-survivor group were significantly lower than that in survivor group, but the TC level [(3.48±0.64)mmol/L vs (2.62±0.47)mmol/L] was significant higher, the differences were statistically significant (P〈0.05). The AUCs for predicting hospital motility were 0.994 (95%CI 0.878, 0.957) for the HDL-C and 0.991(95%CI 0.856, 0.943) for the LDL-C. The TC, HDL-C and LDL-C was correlated significantly with the first 24 h SOFA max score and APACHE Ⅱ score(P〈0.05). Conclusion The serum TC, HDL-C and LDL-C levels is related to the severity of disease, and exhibited discriminative power for prediction of mortality in patients with sepsis.
出处 《中国现代医生》 2016年第13期1-4,共4页 China Modern Doctor
基金 浙江省自然科学基金项目(LY13H150006)
关键词 血脂 脓毒症 HDL-C APACHEⅡ评分 SOFA评分 Serum lipid Sepsis HDL-C APACHE Ⅱ score SOFA score
  • 相关文献

参考文献20

  • 1张志荣,李强.老年脓毒症患者血浆BNP和肌钙蛋白I检测的临床价值[J].中国现代医生,2015,53(19):19-21. 被引量:9
  • 2Seymour CW,Rosengart MR. Septic Shock:Advances in diagnosis and treatment[J]. JAMA, 2015,14(7) : 708-717.
  • 3Gordon BR, Parker TS, Levine DM, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients[J]. Crit Care Med,2001,29 (8) : 1563-1568.
  • 4Tsai MH, Peng YS, Chen YC, et al. Low serum concentra- tion of apolipoprotein A-I is an indicator of poor progno sis in cirrhotic patients with severe sepsis[J]. J Hepatol, 2009,50(5) :906-915.
  • 5Chien JY,Jerng JS, Yu C J, et al. Low serum level of high- density lipoprotein cholesterol is a poor prognostic factor for severe sepsis[J]. Crit Care Med,2005,33 (8) : 1688- 1693.
  • 6Levine DM, Parker TS, Donnelly TM, et al. In vivo protec- tion against endotoxin by plasma high density lipoprotein[]l. Proc Natl Acad Sci USA, 1993,90(24):12.
  • 7Hubsch AP,Powell FS, Lerch PG,et al. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotox- emic rabbits[J]. Circ Shock, 1993,40(1) : 14-23.
  • 8付圆.脓毒症发病机制的研究进展[J].中国现代医生,2014,52(11):155-157. 被引量:29
  • 9Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ES- ICM/ACCP/ATS/SIS international sepsis definitions confer- ence[J]. Intensive Care Med, 2003,29(4) : 530-538.
  • 10Lee SH, Park MS, Park BH, et al. Prognostic implications of serum lipid metabolism over time during Sepsis [J]. Biomed Res Int, 2015,2015 : 789298.

二级参考文献83

  • 1成怡冰,金志鹏,王群思.早期血乳酸清除率对严重脓毒症与脓毒性休克患儿的预后评估[J].中国实用医刊,2010,37(20):21-22. 被引量:8
  • 2王东浩.乳酸清除率评估重度脓毒症患者预后的临床分析[J].中国急救医学,2007,27(1):15-17. 被引量:96
  • 3吴立峰,李子龙,方强.早期乳酸清除率对严重脓毒症、脓毒性休克病人的预后评估作用[J].现代实用医学,2007,19(5):345-347. 被引量:9
  • 4Bone R C,Balk R A,Cerra F B,et al.ACCP/SCCM consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101:1644-1655.
  • 5Levy M M,Fink M P,Marshall J C,et al.2001 SCCM/ ESICM/ ACCP/ ATS/ SIS international sepsis definitions conference 1[J].Intensive Care Med,2003,29:530-538.
  • 6Angus D C,Linde-Zwirble W T,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence:outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310.
  • 7Linde-Zwirble W T,Angus D C.Severe sepsis epidemiology:sampling,selection,and society[J].Crit Care,2004,8:222-226.
  • 8Silva E,de Almeida P M,Sogayar A C B,et al.Brazilian Sepsis Epidemiological Study (BASES study)[J].Crit Care,2004,8:R251-R260.
  • 9Brunkhorst F M,Engel C,Reinhart K,et al.Epidemiology of severe sepsis and septic shock in Germany:results from the German′ Prevalence′ study[J].Crit Care,2005,9:196.
  • 10van Gestel A,Bakker J,Veraart C P W M,et al.Prevalence and incidence of severe sepsis in Dutch intensive care units[J].Crit Care,2004,8:R153-R162.

共引文献84

同被引文献60

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部